ASHER BIOTHERAPEUTICS Trademark

Trademark Overview


On Thursday, November 19, 2020, a trademark application was filed for ASHER BIOTHERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the ASHER BIOTHERAPEUTICS trademark a serial number of 90331121. The federal status of this trademark filing is REGISTERED as of Tuesday, March 28, 2023. This trademark is owned by Asher Biotherapeutics, Inc.. The ASHER BIOTHERAPEUTICS trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical products for the treatment of cancer; pharmaceutical preparations and substances for the treatment of viral, oncological, and immune system related diseases and disorders; medical preparations for the treatment of viral, oncological, and immune system related diseases and disorders

Medical research; pharmaceutical research services; pharmaceutical research and development; scientific research for medical purposes in the fields of cancerous diseases, immunotherapy, autoimmune diseases and disorders, and infectious diseases; development of pharmaceutical preparations and medicines; research and development of pharmaceuticals for the treatment of cancer, immunological diseases and disorders, and infectious diseases; research and development of immunotherapies for the treatment of cancer; providing medical and scientific research information in the field of pharmaceuticals and clinical trials
asher biotherapeutics

General Information


Serial Number90331121
Word MarkASHER BIOTHERAPEUTICS
Filing DateThursday, November 19, 2020
Status700 - REGISTERED
Status DateTuesday, March 28, 2023
Registration Number7013050
Registration DateTuesday, March 28, 2023
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 9, 2021

Trademark Statements


Goods and ServicesPharmaceutical products for the treatment of cancer; pharmaceutical preparations and substances for the treatment of viral, oncological, and immune system related diseases and disorders; medical preparations for the treatment of viral, oncological, and immune system related diseases and disorders
Pseudo MarkASHER BIO THERAPEUTICS
NOT AVAILABLE"BIOTHERAPEUTICS"
Goods and ServicesMedical research; pharmaceutical research services; pharmaceutical research and development; scientific research for medical purposes in the fields of cancerous diseases, immunotherapy, autoimmune diseases and disorders, and infectious diseases; development of pharmaceutical preparations and medicines; research and development of pharmaceuticals for the treatment of cancer, immunological diseases and disorders, and infectious diseases; research and development of immunotherapies for the treatment of cancer; providing medical and scientific research information in the field of pharmaceuticals and clinical trials

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, January 25, 2021
Primary Code005
First Use Anywhere DateFriday, September 23, 2022
First Use In Commerce DateFriday, September 23, 2022

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, January 25, 2021
Primary Code042
First Use Anywhere DateFriday, November 30, 2018
First Use In Commerce DateFriday, November 30, 2018

Trademark Owner History


Party NameAsher Biotherapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Party NameAsher Biotherapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Party NameAsher Biotherapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Trademark Events


Event DateEvent Description
Monday, November 23, 2020NEW APPLICATION ENTERED
Thursday, December 3, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, December 3, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, December 3, 2020TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Thursday, December 3, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, January 25, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, May 1, 2021ASSIGNED TO EXAMINER
Thursday, May 13, 2021NON-FINAL ACTION WRITTEN
Thursday, May 13, 2021NON-FINAL ACTION E-MAILED
Thursday, May 13, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, September 9, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, September 9, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, September 9, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, October 1, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 20, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 9, 2021PUBLISHED FOR OPPOSITION
Tuesday, November 9, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 4, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, May 9, 2022SOU TEAS EXTENSION RECEIVED
Monday, May 9, 2022SOU EXTENSION 1 FILED
Monday, May 9, 2022SOU EXTENSION 1 GRANTED
Wednesday, May 11, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 4, 2023TEAS STATEMENT OF USE RECEIVED
Wednesday, January 4, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, January 4, 2023USE AMENDMENT FILED
Wednesday, January 4, 2023SOU EXTENSION 2 FILED
Thursday, January 19, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, January 19, 2023SOU EXTENSION 2 GRANTED
Thursday, January 19, 2023STATEMENT OF USE PROCESSING COMPLETE
Friday, January 20, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 22, 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, February 23, 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, March 28, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, March 28, 2023REGISTERED-PRINCIPAL REGISTER
Wednesday, September 18, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, September 18, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, September 18, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, September 18, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS